Gotimmune Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Gotimmune General Information
Description
Operator of a biopharmaceutical company intended for the development of therapeutic products. The company develops a portfolio of products with high medical value that ultimately, through global partnerships, will result in successful cures, enabling patients to avail themselves of the treatment of incurable diseases.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Drug Discovery
Primary Office
- Erik Dahlbergsgatan 11A
- floor 2
- 411 26 Gothenburg
- Sweden
+46 070-713 00 00
Gotimmune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Jan-2023 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Gotimmune Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jan Holmgren | Co-Founder | ||
| Nils Lycke Ph.D | Co-Founder |
Gotimmune Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Klementina Österberg | GU Ventures | Chairman | 000 0000 |